Clinical Trials Directory

Trials / Conditions / Pain, Intractable

Pain, Intractable

45 registered clinical trials studyying Pain, Intractable4 currently recruiting.

StatusTrialSponsorPhase
RecruitingSensory Spinal Cord Stimulation
NCT07095036
University of North Carolina, Chapel HillN/A
SuspendedStudy to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer
NCT05067257
Sorrento Therapeutics, Inc.Phase 2
RecruitingA Study of the Safety and Tolerability of GA in the Treatment of Patients With Refractory Neuropathic Pain
NCT06596681
Beijing Tiantan HospitalEARLY_Phase 1
CompletedUse of Ketamine in Severe Pain Syndromes
NCT06537375
Erasme University Hospital
TerminatedStudy to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalitie
NCT05775510
MedtronicNeuro
RecruitingMedullary Stimulation for the Treatment of Refractory Neck Pain (S2M)
NCT05398003
Nantes University HospitalN/A
RecruitingAPP-based Precise Management System of Chronic Intractable Pain
NCT05761392
Beijing Tsinghua Chang Gung HospitalN/A
CompletedImpact of DuoTherm Compared to TENS on Pain and Disability With Acute and Chronic Low Back Pain
NCT04494698
MMJ Labs LLCN/A
CompletedIdentification of Outcome Predictors and Stratification of Responder Profiles Implanted With Spinal Cord Stimu
NCT04587674
Poitiers University HospitalN/A
Active Not RecruitingIntermittent vs. Continuous Dorsal Root Ganglion Stimulation
NCT04727216
Spine and Pain Institute of New YorkN/A
UnknownRadiocontrast Media in the Pulsed Radiofrequency Treatment
NCT04876469
Sanliurfa Education and Research HospitalN/A
CompletedDetermination of Longus Colli Muscle Thickness by Ultrasonography
NCT05108103
Istanbul University
WithdrawnPhase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain
NCT04572776
Sorrento Therapeutics, Inc.Phase 3
CompletedInvestigating Biological Targets, Markers, and Intervention for Chronic Pain
NCT04625504
Vanderbilt University Medical CenterN/A
CompletedHow Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain
NCT04602286
The University of QueenslandN/A
CompletedEfficacy of Ketamine in Post Anesthesia Recovery Room
NCT04701008
University of Alberta
CompletedPsychosocial, Behavioral, and Radiologic Changes Following Radiosurgery for Benign Neurologic Disease
NCT04688554
Vanderbilt University Medical Center
UnknownTransitioning to a Valve -Gated Intrathecal Drug Delivery System
NCT04312685
Bux, Anjum, MDN/A
CompletedComparison of DTM™ SCS Therapy Combined With Conventional Medical Management (CMM) to CMM Alone in the Treatme
NCT06442410
MedtronicNeuroN/A
CompletedSpinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System
NCT04503109
Nalu Medical, Inc.N/A
UnknownStudy of the Impact of the Femoral Implant "Y-strut" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY)
NCT03887494
Assistance Publique - Hôpitaux de ParisN/A
UnknownRopivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain
NCT04085120
All India Institute of Medical SciencesN/A
CompletedPawsitive Impacts of Therapy Dog Visits
NCT04727749
University of SaskatchewanN/A
CompletedPost-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conv
NCT04096391
Evolve Restorative CenterN/A
UnknownPET Patterns, Biomarkers and Outcome in Burst SCS Treated FBSS Patients
NCT03419312
Uppsala UniversityN/A
CompletedBurstDR™ micrOdosing stimuLation in De-novo Patients
NCT03350256
Abbott Medical DevicesN/A
TerminatedHigh-Density Spinal Cord Stimulation for the Treatment of Chronic Intractable Pain Patients
NCT03318172
Seoul National UniversityN/A
CompletedPatient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain
NCT02886286
University Hospitals Cleveland Medical CenterPhase 4
UnknownEfficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic in Cancer Patients With Pain
NCT02687347
McGill University Health Centre/Research Institute of the McGill University Health CentrePhase 3
CompletedOPTIONS Spinal Cord Stimulation Programming Parameters
NCT02503787
MedtronicNeuroN/A
TerminatedImproving Outcomes and Lowering Costs by Integration of Primary Care Providers and Pain Medicine Physicians fo
NCT02484937
Rush University Medical CenterN/A
UnknownObservational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain M
NCT02485795
Proove Bioscience, Inc.
CompletedEfficacy and Safety of Silk Fibroin With Bioactive Coating Layer Dressing
NCT02091076
Chulalongkorn UniversityPhase 1 / Phase 2
CompletedA Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain
NCT02036281
University of Texas Southwestern Medical CenterPhase 1
WithdrawnEffectiveness of Ketamine in Malignant Neuropathic Pain Relief
NCT01951911
Haukeland University HospitalPhase 3
WithdrawnPilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patie
NCT01687751
Fraser HealthPhase 2
CompletedClinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment
NCT01539980
Chulalongkorn UniversityPhase 1 / Phase 2
CompletedPain Blocking During Drug Administration or Blood Collection With Needles
NCT01166906
University of California, Irvine
CompletedEvaluation of Stepped Care for Chronic Pain in Iraq/Afghanistan Veterans (ESCAPE)
NCT00386243
VA Office of Research and DevelopmentN/A
TerminatedA Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic
NCT00381095
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Phase 4
TerminatedCONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic Pain
NCT00122915
MedtronicNeuroPhase 3
CompletedPhase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain-
NCT00216684
Janssen Pharmaceutical K.K.Phase 3
CompletedPhase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of
NCT00216658
Janssen Pharmaceutical K.K.Phase 2
CompletedAn Implantable Spinal Cord Stimulation Pain Management System
NCT00205855
Boston Scientific CorporationPhase 3
CompletedLong-term Effect of Motor Cortex Stimulation in Patients Suffering From Chronic Neuropathic Pain
NCT03189823
Radboud University Medical Center